S Amat Selected Research

Sepsis (Septicemia)

5/2003

Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Amat Research Topics

Disease

5	Breast Neoplasms (Breast Cancer) 11/2017 - 04/2002
3	Neoplasms (Cancer) 11/2017 - 01/2005
1	Neoplasm Metastasis (Metastasis) 11/2017
1	Cystinuria 11/2011
1	Small Cell Carcinoma 01/2008
1	Residual Neoplasm 10/2003
1	Sepsis (Septicemia) 05/2003
1	Neutropenia 05/2003

Drug/Important Bio-Agent (IBA)

1	Small Interfering RNA (siRNA)IBA 11/2017
1	Therapeutic UsesIBA 11/2017
1	Amino Acids FDA Link 11/2011
1	Tamoxifen FDA LinkGeneric 01/2005
1	Docetaxel (Taxotere)FDA Link 05/2003
1	Antineoplastic Agents (Antineoplastics)IBA 05/2003

Therapy/Procedure

4	Neoadjuvant Therapy 01/2005 - 04/2002
2	Induction Chemotherapy 10/2003 - 04/2002
1	Radiotherapy 01/2008
1	Laparotomy 01/2008